In the first half of 2026, China's ibuprofen exports (under HS code 29163920) totaled US$30.2593 million, with a total weight of 3,232,292 kg, covering 67 countries and regions. The United States alone accounted for nearly one-quarter of the total value, while South Korea's unit price reached 3.3 times the global average. The India–Pakistan markets moved large volumes at an average of around US$7/kg, while Europe showed a clear bipolar pattern. With 259 orders and an average order value of US$116,800, the data indicate that ibuprofen exports are dominated by bulk orders, supplemented by small-to-medium batch orders.
| Metric | Value |
|---|---|
| Total orders | 259 |
| Total value | US$30.2593 million |
| Total weight | 3,232,292 kg |
| Average unit price | US$9.36/kg |
| Destinations | 67 countries/regions |
Monthly Trend Analysis
April was the peak month for China's ibuprofen exports by value, reaching US$6.3766 million, while March recorded the lowest at US$3.5209 million, showing notable volatility.
| Month | Orders | Value (US$10,000) | Weight (kg) | Unit Price (US$/kg) |
|---|---|---|---|---|
| Jan | 45 | 488.20 | 505,248 | 9.66 |
| Feb | 41 | 567.82 | 608,533 | 9.33 |
| Mar | 37 | 352.09 | 413,183 | 8.52 |
| Apr | 45 | 637.66 | 670,369 | 9.51 |
| May | 49 | 471.41 | 513,407 | 9.18 |
| Jun | 42 | 508.74 | 521,552 | 9.75 |
Monthly export value trend (Jan–Jun 2026)
Monthly export volume trend (Jan–Jun 2026)
Destination Market Breakdown
The United States ranked first with 24.06% of total value. Pakistan and India together accounted for 24.21%, forming a South Asian “high-volume, low-price” zone. South Korea led the global unit-price rankings at US$30.50/kg, highlighting the premium potential of high-end markets.
Overall, the top 10 destinations concentrated approximately 80% of total export value, showing a strong head effect, while the remaining 57 countries/regions shared the other 20%, presenting a long-tail distribution.
| Rank | Destination | Value (US$10,000) | Weight (kg) | Unit Price (US$/kg) |
|---|---|---|---|---|
| 1 | USA | 728.02 | 661,910 | 10.99 |
| 2 | Pakistan | 389.09 | 550,598 | 7.07 |
| 3 | India | 343.35 | 481,376 | 7.13 |
| 4 | Germany | 204.12 | 139,602 | 14.62 |
| 5 | Mexico | 178.99 | 168,300 | 10.64 |
| 6 | Brazil | 138.16 | 167,006 | 8.27 |
| 7 | Turkey | 128.62 | 161,285 | 7.97 |
| 8 | Russia | 112.81 | 114,132 | 9.88 |
| 9 | South Korea | 110.87 | 36,350 | 30.50 |
| 10 | UAE | 89.67 | 107,500 | 8.34 |
Major export destinations (Jan–Jun 2026)
Regional Strategic Insights
North America: Centered on the U.S., this region exhibits typical high-price, high-margin characteristics, with highly concentrated orders and large transaction sizes. Strategic focus should be on locking in annual framework agreements with key accounts, while prioritizing FDA certification and premium supply-chain access to solidify the premium advantage through quality barriers.
South Asia: Driven by Pakistan and India, this is the world’s largest “volume” market, with average prices around US$7/kg. Success here depends on economies of scale to reduce production costs and maintain market share, while staying alert to price competition from local manufacturers.
Europe: A clear bipolar structure: Western European markets like Germany demand stringent quality standards, making them suitable for promoting high-purity or sustained-release formulations at higher premiums; Eastern European markets such as the Czech Republic are better approached with cost-effective offerings. Overall, Europe accounts for about 15% of total value and serves as an ideal testing ground for brand and technology upgrades.
Latin America: An emerging growth pole with strong demand. The main bottlenecks are lengthy local drug registration processes and high logistics costs. Early investment in local agency networks and warehousing is recommended.
Middle East: Beyond meeting local needs, the UAE’s strong re-export hub function makes it a springboard for radiating into Africa and other neighboring emerging markets.
East Asia: South Korea leads the world with an average price of US$30.50/kg, a unique ultra-high-premium enclave. It is speculated that there is rigid demand for specific crystalline forms or injectable-grade raw materials. A dedicated investigation into South Korean order specifications is advised, and the feasibility of replicating this high-end customization model across other markets should be explored.
Market Outlook
China's ibuprofen exports in the first half of 2026 remained broadly stable, with the U.S. and South Asia forming the two poles, while Europe and Latin America provided diversified support. Future growth opportunities may include:
Drawing on the high-unit-price experiences of South Korea and Germany to develop differentiated specifications and raise per-unit value.
While consolidating the top 10 markets, screening fast-growing,准入-friendly countries in the long tail—such as Vietnam, Nigeria, and Chile—for pilot expansion.
For concentrated markets like the U.S., establishing backup logistics solutions to hedge against geopolitical or tariff volatility.
